RxDoctor Payments Data

John Petrilli, MD

Family Medicine · Tampa, FLNPI 1609213016

Payments from drug & device makers

$725in general payments, 2019–2025

Across 38 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$186
  • Sanofi-aventis U.S. LLC$87
  • Dynavax Technologies Corporation$49
  • Exact Sciences$48
  • Novo Nordisk$45
  • Recor Medical Inc$40
  • plus $270 from 11 others

What the payments were for

  • Food & beverage$70397%
  • Education$223%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$725 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$88,447
Medicare patients
282
Services billed
1,007

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$79,429
XareltoRivaroxaban54$67,864
JardianceEmpagliflozin48$62,383
MounjaroTirzepatide39$49,082
JanuviaSitagliptin Phosphate18$26,705
OzempicSemaglutide17$23,507
TrulicityDulaglutide12$22,922
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,295
LyricaPregabalin12$10,457
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$5,196
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$4,442
Atorvastatin Calcium382$3,407
Rosuvastatin Calcium120$2,209
SynthroidLevothyroxine Sodium30$2,168
Gabapentin98$1,915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Lyrica$29$89,88681 claims
Lilly USA, LLCMounjaro, Trulicity$28$72,00451 claims
Boehringer IngelheimJardiance$25$62,38348 claims
MerckJanuvia$13$26,70518 claims
Novo NordiskOzempic$45$23,50717 claims
GSKTrelegy Ellipta$32$12,29519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →